Weaver Capital Management’s Celularity CELU Stock Holding History

Weaver Capital Management’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$399	Hold	300	–	–	﹤0.01%	171
2026 Q1	$399	Hold	300	–	–	﹤0.01%	173
2025 Q4	$333	Hold	300	–	–	﹤0.01%	183
2025 Q3	$621	Hold	300	–	–	﹤0.01%	190
2025 Q2	$588	Hold	300	–	–	﹤0.01%	187
2025 Q1	$519	Hold	300	–	–	﹤0.01%	183
2024 Q4	$624	Hold	300	–	–	﹤0.01%	184
2024 Q3	$891	Hold	300	–	–	﹤0.01%	171
2024 Q2	$939	Hold	300	–	–	﹤0.01%	167
2024 Q1	$1.57K	Buy	+300	New	+$1.23K	﹤0.01%	161

Other funds holding CELU

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

Weaver Capital Management's CELU Position: Q2 2026 in Review

Weaver Capital Management held its Celularity (CELU) position steady in Q2 2026 at 300 shares worth $399. The position accounts for ﹤0.01% of the portfolio, ranked #171.

Weaver Capital Management first reported a position in CELU in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.57K in Q1 2024. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

Weaver Capital Management held 300 shares of Celularity worth $399 as of Q2 2026.
Weaver Capital Management left its Celularity share count unchanged in Q2 2026.
Celularity made up ﹤0.01% of Weaver Capital Management's portfolio in Q2 2026, its #171 holding.
Weaver Capital Management first reported a position in Celularity in Q1 2024 and has held it in 10 quarters since.
Weaver Capital Management's Celularity position peaked at $1.57K in Q1 2024.
39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on Weaver Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.